Zhang Li, Wang Lingqing, Tao Luyuan, Chen Changgong, Ren Shijia, Zhang Youyou
Department of Cardiovascular Medicine, The First People's Hospital of Taizhou City, Taizhou, China.
Department of Endocrinology, The First People's Hospital of Taizhou City, Taizhou, China.
Front Surg. 2022 Jun 7;9:891047. doi: 10.3389/fsurg.2022.891047. eCollection 2022.
To explore the risk factors of ischemia reperfusion injury (IRI) after percutaneous coronary intervention (PCI) in patients with acute ST-segment elevation myocardial infarction (STEMI) and its influence on prognosis.
The clinical data of 80 patients with STMEI undergoing PCI in our hospital from June 2020 to June 2021 were collected. According to whether IRI occurred after PCI, STMEI patients were divided into IRI group and non-IRI group. The basic information, clinical characteristics, examination parameters and other data of all patients were collected, and the prognosis of the two groups was observed. Risk factors were analyzed by fitting binary Logistic regression model. The survival prognosis was analyzed by Kaplan-Meier survival curve.
Logistic regression analysis showed that type 2 diabetes mellitus (T2DM), pre-hospital delay time (PHD) and door-to-balloon expansion time (DTB) were the influencing factors of IRI in patients with STMEI (< 0.05). MACE occurred in 11 cases (32.35%) in the IRI group and 13 cases (28.26%) in the non-IRI group. Log-rank test showed = 0.503, indicating no statistically significant difference.
T2DM, PHD and DTB were the influencing factors of IRI in patients with STMEI, and IRI will not reduce the prognosis of patients.
探讨急性ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入治疗(PCI)后缺血再灌注损伤(IRI)的危险因素及其对预后的影响。
收集2020年6月至2021年6月在我院接受PCI治疗的80例STMEI患者的临床资料。根据PCI术后是否发生IRI,将STMEI患者分为IRI组和非IRI组。收集所有患者的基本信息、临床特征、检查参数等资料,并观察两组患者的预后情况。采用二元Logistic回归模型进行危险因素分析。采用Kaplan-Meier生存曲线分析生存预后。
Logistic回归分析显示,2型糖尿病(T2DM)、院前延误时间(PHD)和门球扩张时间(DTB)是STMEI患者IRI的影响因素(<0.05)。IRI组发生主要不良心血管事件(MACE)11例(32.35%),非IRI组发生13例(28.26%)。Log-rank检验显示=0.503,差异无统计学意义。
T2DM、PHD和DTB是STMEI患者IRI的影响因素,且IRI不会降低患者的预后。